Covered recipient · General Payments record
MUHAMMED KHOKAR
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2022
$1,923.28
- Reported across 83 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $169.91 | 9 |
| Education | $99.95 | 1 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Incyte Corporation | $142.69 | 3 |
| TAIHO ONCOLOGY, INC. | $41.39 | 2 |
| Janssen Biotech, Inc. | $19.56 | 1 |
| SOBI, INC | $18.60 | 1 |
| TerSera Therapeutics LLC | $18.17 | 1 |
| GlaxoSmithKline, LLC. | $16.93 | 1 |
| Pharmacyclics LLC, An AbbVie Company | $12.52 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. | $16.93 | 03/31/2022 | Food and Beverage | Undisputed | 01/23/2026 | 945134455 | CMS |
| Incyte Corporation | $17.74 | 02/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | 942999747 | CMS |
| Incyte Corporation | $99.95 | 03/22/2022 | Education | Undisputed | 01/23/2026 | 942999753 | CMS |
| Incyte Corporation | $25.00 | 08/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 942999845 | CMS |
| Janssen Biotech, Inc. | $19.56 | 05/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 886746201 | CMS |
| Pharmacyclics LLC, an AbbVie Company | $12.52 | 05/23/2022 | Food and Beverage | Undisputed | 01/23/2026 | 890342411 | CMS |
| Sobi, Inc | $18.60 | 10/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | 940363101 | CMS |
| Taiho Oncology, Inc. | $19.95 | 02/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 924016709 | CMS |
| Taiho Oncology, Inc. | $21.44 | 09/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 924011439 | CMS |
| TerSera Therapeutics LLC | $18.17 | 06/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | 943243267 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.